STOCK TITAN

Werewolf Therapeutics: Balyasny reports 6.26% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Werewolf Therapeutics, Inc. (HOWL) is the issuer in a Schedule 13G reporting that five reporting persons may each be deemed to beneficially own the same 3,040,251 shares for the September 30, 2026 event date. The reporting persons are Balyasny Asset Management L.P.; its general partner, BAM GP LLC; BAM GP’s sole member, Balyasny Asset Management Holdings LP; its general partner, Dames GP LLC; and Dames’ managing member, Dmitry Balyasny. Each reports sole voting and dispositive power over the shares, with no shared power. The reported amount is 6.26% of the class, based on 48,599,066 shares outstanding as of July 27, 2026. Atlas Diversified Master Fund, Ltd., an investment-management client of Balyasny Asset Management L.P., holds the shares directly and has the right to receive dividends and sale proceeds.

Shares beneficially owned 3,040,251 shares Each of the five reporting persons may be deemed to beneficially own the same shares.
Percent of class 6.26% Based on 48,599,066 shares outstanding as of July 27, 2026.
Shares outstanding 48,599,066 shares As of July 27, 2026.
beneficially own financial
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole voting power financial
"has the sole power to vote or to direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"has the sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HOWL shares may Balyasny Asset Management beneficially own?

Balyasny Asset Management L.P. may be deemed to beneficially own 3,040,251 shares, equal to 6.26% of the class. The shares are held directly by Atlas Diversified Master Fund, Ltd., which has the right to receive dividends and sale proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





95075A107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading